ORDENTLICH PETER (Chief Scientific Officer) sold 29.97K shares of SYNDAX PHARMACEUTICALS INC on the open market
Open‑market sale worth $694.1K. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+24.29K
Price / share
$3.08
Trade value
$74.81K
% of position
Common Stock
Shares
+5.68K
Price / share
$3.08
Trade value
$17.51K
% of position
Common Stock
Shares
−5.68K
Price / share
$23.33
Trade value
$132.60K
% of position
Common Stock
Shares
−7.95K
Price / share
$23.58
Trade value
$187.59K
% of position
Common Stock
Shares
−16.33K
Price / share
$22.89
Trade value
$373.92K
% of position
Net shares
+0.00
Net value
-$601.81K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/23/2020 | M · Option Exercise | +24.29K | $3.08 | $74.81K | New position | 0.00 | 24.29K |
| Common Stock Direct | 11/23/2020 | M · Option Exercise | +5.68K | $3.08 | $17.51K | 23.4% | 24.29K | 29.97K |
| Common Stock Direct | 11/23/2020 | S · Sale | −5.68K | $23.33 | $132.60K | 19.0% | 29.97K | 24.29K |
| Common Stock Direct | 11/23/2020 | S · Sale | −7.95K | $23.58 | $187.59K | 32.7% | 24.29K | 16.33K |
| Common Stock Direct | 11/23/2020 | S · Sale | −16.33K | $22.89 | $373.92K | New position | 16.33K | 0.00 |
| Total | +0.00 | -$601.81K | ||||||
Stock Option (Right to Buy)
Common Stock
24.29K shares
Shares
−24.29K
Strike price
3.08
Held after
0.00
Exercisable
—
Stock Option (Right to Buy)
Common Stock
5.68K shares
Shares
−5.68K
Strike price
3.08
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock24.29K shares | 11/23/2020 | M · Option Exercise | −24.29K | 3.08 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Common Stock5.68K shares | 11/23/2020 | M · Option Exercise | −5.68K | 3.08 | — | 0.00 |